Drugs and Devices

FDA approves Elelyso for Gaucher disease

On May 1, the U.S. Food and Drug Administration (FDA) approved Elelyso (taliglucerase alfa) for the treatment of Gaucher disease. Read more.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Test Your Nursing Knowledge

Answer this interactive quiz to be entered to win a gift card.

  • This field is for validation purposes and should be left unchanged.

Insights Blog

Today’s News in Nursing

Shares